Biologic API CDMO Benchmarking Report 2022: Comprehensive Analysis of Current Outsourcing Trends and Practices
June 08, 2022 04:23 ET
|
Research and Markets
Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Biologic API CDMO Benchmarking (7th Ed.)" report has been added to ResearchAndMarkets.com's offering. The Biologic API CDMO Benchmarking (7th...
Global Biologic Drug Product CMO Benchmarking Market 2022: Biologic Drug Product CMO Competitive Landscape and Company Service Quality Profiles
February 22, 2022 05:18 ET
|
Research and Markets
Dublin, Feb. 22, 2022 (GLOBE NEWSWIRE) -- The "Biologic Drug Product CMO Benchmarking" report has been added to ResearchAndMarkets.com's offering. The Biologic Drug Product CMO Benchmarking (5th...
6th Edition Biologic API Contract Manufacturer Quality Benchmarking Market Study
March 05, 2021 05:18 ET
|
Research and Markets
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Biologic API Contract Manufacturer Quality Benchmarking (6th Edition)" report has been added to ResearchAndMarkets.com's offering. This Biologic API...
Global Biologic Drug Product Contract Manufacturer Quality Benchmarking Study 2021
March 02, 2021 07:28 ET
|
Research and Markets
Dublin, March 02, 2021 (GLOBE NEWSWIRE) -- The "Biologic Drug Product Contract Manufacturer Quality Benchmarking (4th Edition)" report has been added to ResearchAndMarkets.com's offering. This...
Opportunities in the Contract Manufacturing Market in China - China's mAb Therapeutics is Forecast to Grow to $26 Billion by 2030
September 08, 2020 07:33 ET
|
Research and Markets
Dublin, Sept. 08, 2020 (GLOBE NEWSWIRE) -- The "Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging Opportunities" report has been added to...